ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating) shares shot up 0.2% during mid-day trading on Monday . The company traded as high as $9.83 and last traded at $9.83. 206 shares changed hands during trading, a decline of 100% from the average session volume of 88,557 shares. The stock had previously closed at […]
ARYA Sciences Acquisition Corp V (NASDAQ:ARYE – Get Rating) shot up 0.3% on Wednesday . The company traded as high as $9.74 and last traded at $9.74. 63,255 shares changed hands during mid-day trading, an increase of 64% from the average session volume of 38,616 shares. The stock had previously closed at $9.71. The business’s […]
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results - read this article along with other careers information, tips and advice on BioSpace
The SPAC merger that Amicus Therapeutics planned for its gene therapy assets has been called off due to market conditions. The rare disease company is instead keeping those assets but streamlining its portfolio in order to save $400 million the amount that the gene therapy spinout was in line to receive from the merger deal.